Andrew S. Davis - May 19, 2023 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
May 19, 2023
Transactions value $
-$132,528
Form type
4
Date filed
8/4/2023, 05:31 PM
Previous filing
May 3, 2023
Next filing
Jul 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $13.3K +507 +0.44% $26.17 116K May 19, 2023 Direct F1
transaction SILK Common Stock Sale -$146K -6.59K -5.67% $22.13 110K Aug 3, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F2 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.